Advertisement

Topics

Janssen launches Phase II/III program of Crohn's disease candidate

05:50 EDT 12 Jul 2018 | SmartBrief

Janssen Research & Development initiated the Phase II/III GALAXI program to assess the safety and efficacy of Tremfya, or gus -More

Original Article: Janssen launches Phase II/III program of Crohn's disease candidate

NEXT ARTICLE

More From BioPortfolio on "Janssen launches Phase II/III program of Crohn's disease candidate"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...